Medtronic offers higher dividend yield and growth, Abbott excels in dividend history and diversification.

Medtronic and Abbott are both strong dividend-paying medical device companies, but Medtronic currently offers a higher dividend yield of 3.11% and stronger near-term growth prospects, including accelerating revenue and a planned diabetes business separation. Abbott, with a 2.4% yield, boasts a longer streak of dividend increases (54 years) and a more diversified business including diagnostics and pharmaceuticals, supported by its recent $21 billion Exact Sciences acquisition. Medtronic trades at a lower valuation, making it a better choice for income-focused retirees, while Abbott suits investors seeking long-term growth and stability. The decision hinges on income needs versus growth and quality preferences.